射频消融治疗甲状腺癌的现状与思考

Current situation and thoughts on radiofrequency ablation in the treatment of thyroid cancers

在甲状腺外科领域,射频消融最初主要用于治疗甲状腺癌术后颈部孤立淋巴结转移,近年来逐渐用于治疗甲状腺良性结节.然而,目前国内存在随意扩大适应证、盲目开展射频消融的现象,将其用于可手术甲状腺癌的初始治疗,现有甲状腺结节射频消融共识和甲状腺癌治疗指南均对此持反对态度.因此,在以循证医学证据为基础的指南推荐颁布之前,应避免将射频消融用于可手术甲状腺癌的初始治疗.

Radiofrequency ablation （RFA） was originally used primarily for the treatment of regional metastatic lymph nodes from recurrent thyroid cancers in the field of thyroid surgery.In recent years it is gradually used to treat a part of benign thyroid nodules.However,the domestic issues resulting from indiscriminately enlarged RFA indication and lack of standardization of therapy become more and more prominent,including initial treatment of operable thyroid cancers by RFA,which is against by the current consensus about RFA for patients with thyroid nodules and management guidelines for patients with thyroid cancers.Therefore,RFA should be avoided for initial treatment of operable thyroid cancers before the introduction of guidelines based on evidence-based medicine.